DE69231583D1 - Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält. - Google Patents

Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.

Info

Publication number
DE69231583D1
DE69231583D1 DE69231583T DE69231583T DE69231583D1 DE 69231583 D1 DE69231583 D1 DE 69231583D1 DE 69231583 T DE69231583 T DE 69231583T DE 69231583 T DE69231583 T DE 69231583T DE 69231583 D1 DE69231583 D1 DE 69231583D1
Authority
DE
Germany
Prior art keywords
insulin
composition
treating
deficiency
mammals containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69231583T
Other languages
English (en)
Other versions
DE69231583T2 (de
Inventor
J Rink
A Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Publication of DE69231583D1 publication Critical patent/DE69231583D1/de
Application granted granted Critical
Publication of DE69231583T2 publication Critical patent/DE69231583T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69231583T 1991-05-24 1992-05-23 Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält. Expired - Lifetime DE69231583T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
PCT/US1992/004351 WO1992020366A1 (en) 1991-05-24 1992-05-23 Insulin and amylin containing composition for the treatment of insulin deficient mammals

Publications (2)

Publication Number Publication Date
DE69231583D1 true DE69231583D1 (de) 2001-01-04
DE69231583T2 DE69231583T2 (de) 2001-03-29

Family

ID=24831674

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231583T Expired - Lifetime DE69231583T2 (de) 1991-05-24 1992-05-23 Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.

Country Status (11)

Country Link
EP (1) EP0586592B1 (de)
JP (1) JPH06510753A (de)
AT (1) ATE197764T1 (de)
AU (2) AU2169392A (de)
CA (1) CA2109604A1 (de)
DE (1) DE69231583T2 (de)
DK (1) DK0586592T3 (de)
ES (1) ES2153828T3 (de)
GR (1) GR3035287T3 (de)
SG (1) SG44838A1 (de)
WO (1) WO1992020366A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109794A1 (en) * 1991-05-24 1992-11-26 Timothy J. Rink Amylin and possibly insulin containing composition for the treatment of anorexia and related states
WO2001000223A2 (en) * 1999-06-25 2001-01-04 Minimed Inc. Multiple agent diabetes therapy
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment

Also Published As

Publication number Publication date
EP0586592B1 (de) 2000-11-29
ATE197764T1 (de) 2000-12-15
JPH06510753A (ja) 1994-12-01
CA2109604A1 (en) 1992-11-26
EP0586592A1 (de) 1994-03-16
ES2153828T3 (es) 2001-03-16
SG44838A1 (en) 1997-12-19
AU2169392A (en) 1992-12-30
AU6196496A (en) 1996-10-10
GR3035287T3 (en) 2001-04-30
DK0586592T3 (da) 2000-12-27
DE69231583T2 (de) 2001-03-29
WO1992020366A1 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
PH24867A (en) A method of treating conditions associated with photodamaged skin by using pharmaceutical compositions containing p(22-(5,6,7,8 tetrahydro-5,5,8,8-tetramethyl-2-naphtyl)propenyl)phenylsulfone and derivatives thereof
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
GB8319073D0 (en) Fatty acid compositions
DK0455783T3 (da) Anvendelse af nervonsyre og langkædede fedtsyrer til behandlingen af demyeliniserende sygdomme
HU905682D0 (en) Early ejaculation treatment by using sertraline
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
ES2174838T3 (es) Metodo para aumentar la absorcion del intestino.
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DE69231583T2 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
DE69034076T2 (de) Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
HUT61485A (en) Process for producing drug composition suitable for treating thrombocytopenia
PH24445A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
NZ216519A (en) Polycyclic compounds and pharmaceutical compositions
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder

Legal Events

Date Code Title Description
8364 No opposition during term of opposition